Literature DB >> 23126599

The ex vivo induction of human CD103⁺ CD25hi Foxp3⁺ CD4⁺ and CD8⁺ Tregs is IL-2 and TGF-β1 dependent.

B Gunnlaugsdottir1, S M Maggadottir, I Skaftadottir, B R Ludviksson.   

Abstract

The expression of the integrin αE (CD103), may enhance the retention of regulatory T cells to peripheral inflammatory sites and possibly contribute to their suppressive potential. The aim of this study was to define the regulatory role of IL-2 and TGF-β1 on the CD103 expression and the optimal in vitro conditions for the induction/expansion of human CD4(+) and CD8(+) Tregs. Cord blood mononuclear cells (CBMC) were stimulated under various culture conditions, including anti-CD3, anti-CD28, IL-2 and TGF-β1. TGF-β1 and IL-2 were both required for optimal expression of CD103. In addition, TGF-β1 and IL-2 synergistically induced CD103 expression on CD8(+) T cells, whereas, only additive induced expression was noted on CD4(+) T cells. Surprisingly, CD103 expression was not dependent upon CD28 costimulation. IL-2 also played a central role in CD103 expression by CD25(hi) Foxp3+ Tregs. IL-2, TGF-β1 and anti-CD3 defined the optimal stimulatory conditions favouring the induction/expansion of both CD4(+) and CD8(+) human Tregs from naive CBMC. Thus, this study provides new insights into the regulatory role of IL-2 upon CD103 expression by human cord blood CD4(+) and CD8(+) T cells. Furthermore, it identifies the in vitro culture conditions driving the differentiation of the novel phenotype CD4(+) and CD8(+) CD103(+) CD25(hi) Foxp3+ Tregs from human CBMC.
© 2012 The Authors. Scandinavian Journal of Immunology © 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23126599     DOI: 10.1111/sji.12009

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  6 in total

Review 1.  Regulatory T cells in acute and chronic kidney diseases.

Authors:  Rahul Sharma; Gilbert R Kinsey
Journal:  Am J Physiol Renal Physiol       Date:  2017-09-06

2.  MiR-21 controls in situ expansion of CCR6⁺ regulatory T cells through PTEN/AKT pathway in breast cancer.

Authors:  Yan Hu; Chunhong Wang; Yongju Li; Juanjuan Zhao; Chao Chen; Ya Zhou; Yijin Tao; Mengmeng Guo; Nalin Qin; Tao Ren; Zhenke Wen; Lin Xu
Journal:  Immunol Cell Biol       Date:  2015-03-04       Impact factor: 5.126

3.  Endoscopic and clinicopathological characteristics of gastrointestinal adult T-cell leukemia/lymphoma.

Authors:  Hideki Ishibashi; Satoshi Nimura; Yoshiyuki Kayashima; Yasushi Takamatsu; Hiroki Iwasaki; Naohiko Harada; Seiya Momosaki; Hidenori Takedatsu; Shotaro Sakisaka; Morishige Takeshita
Journal:  J Gastrointest Oncol       Date:  2019-08

4.  Human CD8+CD28- T Suppressor Cells Expanded by IL-15 In Vitro Suppress in an Allospecific and Programmed Cell Death Protein 1-Dependent Manner.

Authors:  Fu Feng; Yanjun Liu; Guihuan Liu; Ping Zhu; Manman Zhu; Hua Zhang; Xiao Lu; Jiumin Liu; Xunrong Luo; Yuming Yu
Journal:  Front Immunol       Date:  2018-06-22       Impact factor: 7.561

Review 5.  Newly Found Peacekeeper: Potential of CD8+ Tregs for Graft-Versus-Host Disease.

Authors:  Weihao Wang; Tao Hong; Xiaoqi Wang; Rui Wang; Yuxuan Du; Qiangguo Gao; Shijie Yang; Xi Zhang
Journal:  Front Immunol       Date:  2021-11-24       Impact factor: 7.561

6.  Increased frequency of CD4 and CD8 regulatory T cells in individuals under 15 years with multibacillary leprosy.

Authors:  Camila Fernandes; Heitor Sá Gonçalves; Paula Brito Cabral; Helena Câmara Pinto; Maria Isabel Moraes Pinto; Lilia Maria Carneiro Câmara
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.